Tarsons Products Intrinsic Value

TARSONS • Healthcare
Current Stock Price
₹230.28
Primary Intrinsic Value
₹69.08
Market Cap
₹253.3 Cr
+100.0% Upside
Median Value
₹460.56
Value Range
₹69 - ₹576
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

TARSONS Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹69.08 ₹55.26 - ₹82.90 -70.0% EPS: ₹2.48, Sector P/E: 22x
Book Value Method asset ₹575.70 ₹518.13 - ₹633.27 +150.0% Book Value/Share: ₹572.73, P/B: 2.0x
Revenue Multiple Method revenue ₹460.56 ₹414.50 - ₹506.62 +100.0% Revenue/Share: ₹392.73, P/S: 2.0x
EBITDA Multiple Method earnings ₹460.56 ₹414.50 - ₹506.62 +100.0% EBITDA: ₹132.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹575.70 ₹460.56 - ₹690.84 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹69.08 ₹62.17 - ₹75.99 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹69.08 ₹62.17 - ₹75.99 -70.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹178.77 ₹160.89 - ₹196.65 -22.4% EPS: ₹2.48, BVPS: ₹572.73
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check TARSONS share price latest .

Valuation Comparison Chart

TARSONS Intrinsic Value Analysis

What is the intrinsic value of TARSONS?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Tarsons Products (TARSONS) is ₹460.56 (median value). With the current market price of ₹230.28, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹69.08 to ₹575.70, indicating ₹69.08 - ₹575.70.

Is TARSONS undervalued or overvalued?

Based on our multi-method analysis, Tarsons Products (TARSONS) appears to be trading below calculated value by approximately 100.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.89 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Debt to Equity Ratio 1.71 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 1.9% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 27.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.40x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹114 Cr ₹42 Cr Positive Free Cash Flow 7/10
March 2024 ₹103 Cr ₹-40 Cr Positive Operating Cash Flow 6/10
March 2022 ₹84 Cr ₹15 Cr Positive Free Cash Flow 7/10
March 2021 ₹68 Cr ₹36 Cr Positive Free Cash Flow 8/10